Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-103150
- form_type
- 8-K
- ticker
- XLO
- cik
- 0001840233
- company_name
- Xilio Therapeutics, Inc.
- filed_at
- 2026-03-12T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.483004+00:00
- generated_at
- 2026-05-15T13:49:47.993236+00:00
- sec_items
- ["3.03", "5.03", "9.01"]
- event_type
- regulatory
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-103150
- json_url
- https://secwatch.observer/filing/0001193125-26-103150.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-103150.md
- text_url
- https://secwatch.observer/filing/0001193125-26-103150.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1840233/000119312526103150/0001193125-26-103150-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1840233/000119312526103150/xlo-20260312.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SDOT
Nasdaq notifies Sadot Group of stockholders' equity deficiency; delisting risk
Sadot Group Inc.
May 6, 2026, 7:59 PM ET
regulatory
Items 3.01, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: regulatory
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On or about May 1, 2026, the Company filed a Certificate of Amendment to Designation - After Issuance of Class or Series with the Secretary of State of the State of Nevada amending the provisions of its Articles of Incorporation regarding authorized capital stock.
Filing page
SEC filing
SBEV
Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M
SPLASH BEVERAGE GROUP, INC.
May 5, 2026, 7:59 PM ET
regulatory
Items 1.01, 1.02, 3.01, 3.02, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: regulatory
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On May 4, 2026, the Company filed a Certificate of Withdrawal (the “Withdrawal of Designation”) with the Secretary of State of the State of Nevada and terminated the designation of its Series D Convertible Preferred Stock, par value $0.001 per share (the “Series D”). At the time of filing the Withdrawal of Designation, there were no shares of Series D issued and outstanding. The Withdrawal of Designation became effective upon filing.
Filing page
SEC filing
IOT
Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026
Samsara Inc.
June 1, 2026, 4:07 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time
Filing page
SEC filing
GIG
GigCapital7 domestication from Cayman Islands to Delaware effective May 8 after shareholder vote
GigCapital7 Corp.
May 11, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On May 8, 2026, GigCapital7 effectuated the Domestication by filing (i) a voluntary declaration pursuant to Section 206(3) of the Companies Act (revised) of the Acts of the Cayman Islands, (ii) a certificate of corporate domestication with the Secretary of State of the State of Delaware (the “ DE SoS ”), and (iii) an interim certificate of incorporation with the DE SoS (the “ Domesticated GigCapital7 Charter ”). Domesticated GigCapital7 also adopted bylaws (the “ Domesticated GigCapital7 Bylaws ” and together with the Domesticated GigCapital7 Charter, the “ Domesticated GigCapital7 Governing Documents ”) in connection with the Domestication.
Filing page
SEC filing
WAMFF
Alaska Silver simplifies capital structure, eliminates dual-class shares
Alaska Silver Corp.
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the "Company"), approved an amendment (the "Amendment") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of "Common Shares," no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.
Filing page
SEC filing
JPM
JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP
JPMORGAN CHASE & CO
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock
Filing page
SEC filing
KALA
KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026
KALA BIO, Inc.
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
On May 7, 2026, KALA BIO, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-50 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on May 8, 2026 (the “ Reverse Stock Split ”).
Filing page
SEC filing
ENZN
Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%
Viskase Holdings, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
similar materiality
This filing
On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, which will effect, as of 5:00 p.m. Eastern Time, on March 13, 2026 (the “Effective Time”), a 1-for-14 reverse stock split (the “Reverse Stock Split”) of the issued and outstanding shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
Comparable filing
In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.